The present study investigated, for the first time, whether cranberry (Pacran) supplementation could modulate the expression of the transcription factors NF-kB and Nrf2, the inflammatory markers (IL-6 and CRP), and lipid peroxidation (TBARS) in patients with CKD. The gene discussed is CRP; the disease is chronic kidney disease.